- Home
- DIBS vs CNTX Comparison
DIBS vs CNTX Comparison
Compare DIBS & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- CNTX
- Stock Information
- Founded
- DIBS 2000
- CNTX 2015
- Country
- DIBS United States
- CNTX United States
- Employees
- DIBS N/A
- CNTX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- CNTX Health Care
- Exchange
- DIBS Nasdaq
- CNTX Nasdaq
- Market Cap
- DIBS 88.1M
- CNTX 78.0M
- IPO Year
- DIBS 2021
- CNTX 2021
- Fundamental
- Price
- DIBS $2.67
- CNTX $0.58
- Analyst Decision
- DIBS Hold
- CNTX Strong Buy
- Analyst Count
- DIBS 1
- CNTX 4
- Target Price
- DIBS N/A
- CNTX $6.00
- AVG Volume (30 Days)
- DIBS 123.4K
- CNTX 390.0K
- Earning Date
- DIBS 08-05-2025
- CNTX 08-06-2025
- Dividend Yield
- DIBS N/A
- CNTX N/A
- EPS Growth
- DIBS N/A
- CNTX N/A
- EPS
- DIBS N/A
- CNTX N/A
- Revenue
- DIBS $88,740,000.00
- CNTX N/A
- Revenue This Year
- DIBS $3.02
- CNTX N/A
- Revenue Next Year
- DIBS $6.51
- CNTX N/A
- P/E Ratio
- DIBS N/A
- CNTX N/A
- Revenue Growth
- DIBS 4.93
- CNTX N/A
- 52 Week Low
- DIBS $2.30
- CNTX $0.49
- 52 Week High
- DIBS $5.00
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- DIBS 50.20
- CNTX 44.00
- Support Level
- DIBS $2.53
- CNTX $0.56
- Resistance Level
- DIBS $2.86
- CNTX $0.63
- Average True Range (ATR)
- DIBS 0.18
- CNTX 0.08
- MACD
- DIBS -0.00
- CNTX 0.00
- Stochastic Oscillator
- DIBS 49.59
- CNTX 27.68
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.